title: Two years survival of primary cardiac leiomyosarcoma managed by surgical and adjuvant therapy.
abstract: BACKGROUND
  Cardiac tumors are a very rare entity. Leiomyosarcoma represents less than 1% of cases.
  
  
  METHODS
  a 51-year-old woman diagnosed with primary left atrium leiomyosarcoma. She was treated by optimal surgery and adjuvant chemotherapy. She is still alive after a follow-up of 24 months without evidence of local or distant recurrence.
  
  
  CONCLUSIONS
  Cardiac leiomyosarcoma is a rare tumor with a dismal prognosis. Surgery is the mainstay of treatment. Adjuvant treatment is still controversial.
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: K
authors.identifier: 0000-0002-1909-3249
authors.initials: K
authors.lastname: Behi
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: M
authors.initials: M
authors.lastname: Ayadi
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: E
authors.initials: E
authors.lastname: Mezni
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: K
authors.initials: K
authors.lastname: Meddeb
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: A
authors.initials: A
authors.lastname: Mokrani
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: Y
authors.initials: Y
authors.lastname: Yahyaoui
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: F
authors.initials: F
authors.lastname: Ksontini
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: H
authors.initials: H
authors.lastname: Rais
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: N
authors.initials: N
authors.lastname: Chrait
authors.affiliation: Medical Oncology Department, Salah Azaeiz Institute, Tunis, Tunisia.
authors.forename: A
authors.initials: A
authors.lastname: Mezlini
keywords: Cardiac tumors; Chemotherapy; Leiomyosarcoma; Survival